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myocarditis, affected individuals can develop dilated cardi-
omyopathy (DCM) [4]. Approximately half of patients with 
DCM undergo heart transplantations due to the lack of ef-
fective chemotherapy. Enteroviruses are commonly suspect-
ed in DCM patients because the genomic material can be de-
tected in up to 70% of patients, and serologically, virus-reac-
tive neutralizing antibodies can be found in 50% of patients 
[2]. The question to be addressed is how virus infection can 
promote DCM. Auto immunity is one possible mechanism, 
as evidenced in patients with myocarditis/DCM by the pres-
ence of autoantibodies to various cardiac antigens, such as 
cardiac myosin heavy chain (Myhc)-α, adenine nucleotide 
translocator (ANT), β-adrenergic receptor-1, branched chain 
α-ketoacid dehydrogenase (BCKD), laminin, and muscarinic 
receptor; Myhc-α is a well-characterized antigen [5,6].
Based on cellular infiltrations, forms of myocarditis have 
been classified as lymphocytic, giant cell, and eosinophilic, 
and various infectious (viruses, bacteria, protozoa, helm-
inthes) and noninfectious (drugs, metals, chemicals) agents 
1. Introduction
Heart failure is the leading cause of death in the United 
States. It is estimated that 80 million American adults have 
some form of cardiovascular disease, with a projected inci-
dence of 40% by 2030 [1]. The potential causes of heart failure 
include pericardial, coronary artery, or heart valve diseas-
es, idiopathic cardiomyopathy, chronic ischemia, and myo-
carditis.
Myocarditis is an inflammation of the myocardium, but 
only 10% of those affected show clinical manifestations 
of the disease [2]. Nonetheless, myocarditis is still regard-
ed as an important cause of heart failure in children and 
adolescents, particularly athletes, indicating that a low de-
gree of inflammation could be present in the hearts of ap-
parently healthy individuals. This hypothesis was support-
ed by a study of autopsies in more than 12,000 accidental 
deaths, which showed evidence of lymphocytic myocarditis 
in 1.06% of individuals [3], raising a question as to the trigger 
of inflammation in heart tissues. Furthermore, as a sequel to 
Published in Clinical Immunology (2012) 144: 237-249. DOI: 10.1016/j.clim.2012.07.003. Copyright 2012, Elsevier. 
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Abstract
Enteroviruses like coxsackievirus B3 (CVB3) are common suspects in myocarditis/dilated cardiomyopathy patients. Autoim-
munity has been proposed as an underlying mechanism, but direct evidence of its role is lacking. To delineate autoimmune re-
sponse in CVB3 myocarditis, we used IAk dextramers for cardiac myosin heavy chain (Myhc)-α 334–352. We have demonstrat-
ed that myocarditis-susceptible A/J mice infected with CVB3 generate Myhc-α-reactive CD4 T cells and such a repertoire was 
absent in naïve mice as measured by proliferative response to Myhc-α 334–352 and IAk dextramer staining. We also detected 
Myhc-α 334–352 dextramer+ cells in the hearts of CVB3-infected mice. The autoreactive T cell repertoire derived from infected 
mice contained a high frequency of interleukin-17-producing cells capable of inducing myocarditis in naïve recipients. The data 
suggest that CVB3, a bona fide pathogen of cardiovascular system that primarily infects the heart can lead to the secondary gen-
eration of autoreactive T cells and contribute to cardiac pathology.
Abbreviations: 7-AAD, 7-aminoactinomycin D; ANT, adenine nucleotide translocator; BCKD, branched chain α-ketoacid dehydrogenase; CPE, 
cytopathic effect; Con-A, concanavalin-A; cpm, counts per minute; CVB3, coxsackievirus B3; DCM, dilated cardiomyopathy; EAM, experimen-
tal autoimmune myocarditis; FC, flow cytometry; GM-CSF, granulocyte macrophage-colony stimulating factor; IFN, interferon; IL, interleu-
kin; IRBP, interphotoreceptor retinoid-binding protein; LN, lymph nodes; MHC, major histocompatibility complex; MNC, mononuclear cells; 
Myhc-α, cardiac myosin heavy chain-α; NASE, neuraminidase; PI, postinfection; PMA, phorbol 12-myristate 13-acetate; RNase, ribonuclease; 
TCID50, 50% tissue culture infective dose; Th, T helper; TNF, tumor necrosis factor; TNI, cardiac troponin I.
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2.2. Virus propagation, titration, and disease-induction
Vero cells (ATCC, Manassas, Virginia) were grown to 80 
to 90% confluence in 75 cm2 flasks in EMEM supplement-
ed with 10% fetal bovine serum (FBS). After removing the 
medium, the adherent monolayer of cells was infected with 
CVB3 (Nancy strain, ATCC) with multiplicity of infection 1 
in EMEM containing no FBS [9]. The virus was allowed to 
adsorb to the cells by incubating the flasks at 37°C for 1 h 
with gentle intermittent rotations every 10 to 15 min. Main-
tenance medium containing 2% FBS was then added and in-
cubation was continued. After confirming the cytopathic ef-
fect (CPE) of the virus, the infected culture flasks were sub-
jected to three rounds of freezing and thawing, and the cul-
ture supernatants containing virus were harvested by centri-
fuging cell lysates at 6000 rpm for 10 min at 4°C, aliquoted, 
and stored at -80°C until further use.
Fifty µl of Vero cells prepared to a density of 5 × 105 cells/ml 
in EMEM/10% FBS was added in eight replicates for each di-
lution of the virus, plus four replicates as controls, in 96-well 
plates, which was incubated at 37°C for 1 h. Ten-fold serial 
dilutions of virus stock (10-1 to 10-8) were made in EMEM and 
50 µl of these suspensions were added into the correspond-
ing replicates, whereas control wells received only EMEM. 
The plates were scored for CPE up to 7 days, and 50% tissue 
culture infective dose (TCID50) values were determined ac-
cording to the Reed–Muench method [17].
The virus stock with known titers was diluted in 1 × 
phosphate-buffered saline (PBS) to contain 25 to 1 × 105 
TCID50/100 µl, and the virions were injected into A/J mice 
i.p., whereas control animals received 1 × PBS only. The an-
imals were monitored for clinical illness and/or mortalities, 
if any, and the surviving animals were sacrificed on day 21 
postinoculation. Hearts and pancreases were harvested for 
histology, spleens and lymph nodes (LN) were collected for 
in vitro experimentation.
2.3. Histopathology
Hearts and pancreases were fixed by immersion in 10% 
phosphate buffered formalin, and three cross-sectional lev-
els of each were sectioned in 5 µm thickness and stained with 
hematoxylin and eosin (H and E) [18]. Hearts and pancre-
ases were evaluated for inflammation and necrotic changes 
and scored for severity based on the numbers of inflammato-
ry foci added across all sections. The degree of inflammation 
was scored as normal (0), mild multifocal (1–5 foci), mod-
erate multifocal to coalescing (6–25 foci), and severe (26 or 
more foci) [19].
2.4. Peptide synthesis
Myhc-α-334–352 (DSAFDVLSFTAEEKAGVYK), cardiac 
troponin I (TNI157–171: QALLGTRAKESLDLR), interpho-
toreceptor retinoid-binding protein (IRBP 201–216: ADKDV-
VVLTSSRTGGV), and bovine ribonuclease (RNase) 43–56 
(VNTFVHESLADVQA) were synthesized on 9-fluorenylm-
ethyloxycarbonyl chemistry (Neopeptide, Cambridge, Mas-
sachusetts). All peptides were HPLC-purified (N 90%), iden-
tity was confirmed by mass spectroscopy, and dissolved in 1 
× PBS prior to use.
2.5. T cell proliferation assay
Single-cell suspensions were prepared from a pool of 
have been implicated in the causation of myocarditis. Promi-
nent among the infectious causes are viruses, importantly en-
teroviruses like coxsackievirus B3 (CVB3). To study the im-
mune events of myocardial injuries in CVB3 infection, vari-
ous rodent models have been developed. For example, the 
virus induces myocarditis in susceptible strains of A/J (H-
2a) and Balb/C (H-2d) mice, the histologic features of which 
resemble those in human disease [7].The disease course has 
two distinct stages that occur in continuum: the acute phase, 
in which infectious virus is present causing damage to cardi-
ac myocytes; and the chronic phase, in which inflammation 
persists, although the extent of virus replication is much re-
duced due to selection of a defective virus [8,9]. This is con-
sistent with the observation that infectious CVB3 cannot be 
isolated in cardiac tissues from patients with DCM [2,10].
The long-standing question is whether this inflammatory 
process occurs due to an autoimmune response to cardiac 
antigens. Importantly, the same strains of mice that are sus-
ceptible to chronic myocarditis and DCM after viral infec-
tion also are susceptible to disease induction by immuniza-
tion with Myhc-α. In contrast, the strains that develop only 
limited acute myocarditis are resistant to Myhc-α-induced 
disease [11]. In addition, susceptible mice made tolerant to 
Myhc-α fail to develop myocarditis after viral infection [12]. 
It was previously shown that lymphocytes isolated on day 
7 postinfection (PI) from Balb/C mice infected with CVB3 
were lytic to cardiomyocytes, but their putative target anti-
gens were not characterized [13,14]. Furthermore, these cyto-
toxic lymphocytes induced the disease in naïve mice infect-
ed with or without CVB3 prior to the transfer [14,15]. While 
these observations point to a role for autoreactive T cells in 
the mediation of CVB3 myocarditis, it is critical to delineate 
both the mechanisms of their generation and their target an-
tigens in cardiac tissues.
With the establishment of experimental autoimmune myo-
carditis (EAM) disease models induced with various cardi-
ac antigens, it is now generally accepted that autoreactive 
CD4 T helper (Th) cells play a pivotal role in the mediation 
of autoimmune myocarditis [16]. The relevance of autoreac-
tive CD4 T cells is further emphasized by the fact that histo-
logic features of EAM closely mimic those of postinfectious 
myocarditis induced with CVB3 [6,8]. Therefore, to study the 
role of autoreactive CD4 T cells in the occurrence of CVB3 
myocarditis, we recently created major histocompatibili-
ty complex (MHC) class II/IAk dextramers for Myhc-α 334–
352, which permitted us to enumerate the frequencies of an-
tigen-specific T cells in infected mice. Using these reagents, 
we demonstrated that A/J mice infected with CVB3 devel-
op myocarditis accompanied with the generation of Myhc-
α-specific CD4 T cells and they infiltrate into the hearts of 
infected animals. We noted that the autoreactive T cells ob-
tained from CVB3-infected mice contain a significant propor-
tion of interleukin (IL)-17-producing cells capable of induc-
ing myocarditis in naïve mice.
2. Materials and methods
2.1. Mice
Six-to-eight-week-old A/J and B10.A mice were procured 
from the Jackson Laboratory (Bar Harbor, Maine). The mice 
were maintained according to the animal protocol guidelines 
of the University of Nebraska-Lincoln, Lincoln, Nebraska.
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hearts were collected and minced. The tissue suspensions 
were incubated with a buffer containing 1 × PBS, collage-
nase IV (Worthington, Lakewood, New Jersey), and 2% FBS 
at 37°C for 15 min in a shaker with continuous agitation. The 
digested tissues were passed through an 18 G needle and in-
cubated for an additional 10 min; cell pellets were obtained 
by centrifugation and resuspended in 40% buffered per-
coll. Cell suspensions were then overlaid with 75% percoll 
and centrifuged, and the interphase representing mononu-
clear cells (MNC) was collected and washed [24]. The iden-
tities of different subsets of MNC were verified by FC. Final-
ly, MNC were stained with Myhc-a 334–352 or RNase 43–56 
dextramers, anti-CD4, and 7-AAD, and frequencies of Myhc-
α-specific cells were determined as above.
2.7. Intracellular cytokine staining
To enumerate the frequencies of cytokine-producing cells 
in naïve mice, lymphocytes were stimulated with phorbol 
12-myristate-13 acetate (PMA: 20 ng/ml) and ionomycin (300 
ng/ml; Sigma-Aldrich) for 5 h in the presence of 2 mM mon-
ensin (Golgi stop, BD Pharmingen, San Diego, California) 
[20,25]. After staining with anti-CD4 and 7-AAD, cells were 
fixed, permeabilized, and stained with anti-cytokine anti-
bodies or isotype controls (eBioscience), and acquired by FC. 
Frequencies of cytokine-producing cells were then enumer-
ated in the live (7-AAD-) CD4+ subset. Likewise, cytokine-
producing cells from CVB3-infected mice were analyzed ex 
vivo as above. However, to determine the frequencies of cy-
tokine-producing autoreactive T cells from CVB3-infected 
mice, lymphocytes were stimulated with Myhc-α 334–352 
(100 µg/ml) for 2 days and the cultures were maintained in 
IL-2 medium. On day 5, cells were stimulated with PMA and 
ionomycin, and frequencies of cytokine+ CD4 T cells were 
determined as above. The clones of anti-cytokine antibodies 
used were: interferon (IFN)-γ (XMG1.2), IL-4 (11B11), IL-10 
(JES5-16E3), IL-17A (eBio17B7), IL-17F (eBio18F10), granulo-
cyte macrophage colony-stimulating factor (GM-CSF, MPI-
22E9), all from eBioscience; and IL-22 (140301; R&D Systems, 
Minneapolis, Minnesota).
2.8. Adoptive transfer myocarditis
Groups of A/J mice were infected with CVB3 (50 TCID50/
animal), and 21 days later, spleens, and LN were collected 
and single cell suspensions were prepared [26]. Cells were 
stimulated with Concanavalin-A (Con-A; 1 µg/ml) for 2 days 
and viable lymphoblasts were harvested and transferred i.p., 
into whole body irradiated naïve A/J mice (400 rads/ ani-
mal; 12×107 cells/animal). Each mouse additionally received 
pertussis toxin (PT, 100 ng; List Biologicals, Campbell, Cali-
fornia) on days 0 and 2 posttransfer as described previously 
[19,27,28]. The animals were euthanized on day 21 posttrans-
fer, and hearts and pancreases were collected for histologi-
cal evaluation of inflammatory changes. To address whether 
Myhc-α-reactive CD4 T cells generated in infected mice can 
transfer the disease, we first stimulated the lymphocytes ob-
tained from CVB3-infected mice with Myhc-α 334–352 (100 
µg/ml) for 2 days and the cultures were maintained in IL-2 
medium. On day 5 poststimulation, CD4 T cells were isolat-
ed by magnetic separation, and after resting for 2 days in 
growth medium, cells were expanded with Con-A for 24 h, 
and transferred into naïve mice (0.18×107 cells/animal). The 
spleens and LN (hereafter termed lymphocytes) harvest-
ed from CVB3-infected mice on day 21 PI, and the cell pel-
lets were resuspended in 1 × ammonium chloride potassium 
buffer (Lonza, Walkersville, Maryland) to lyse erythrocytes 
as described [19]. Likewise, lymphocytes also were prepared 
from naïve mice. After washing, cell pellets were resuspend-
ed in RPMI medium supplemented with 10% FBS, 1 mM so-
dium pyruvate, 4mM L-glutamine, 1 × each of non-essential 
amino acids and vitamin mixture, and 100 U/ml penicillin–
streptomycin (Lonza; hereafter called growth medium), and 
cell viability was verified by trypan blue staining. Cells wer-
estimulated at a density of 5 × 106 cells/ml in triplicates with 
the indicated peptides (0–100 µg/ml) for 2 days in growth 
medium; the cells cultured with no peptides served as me-
dium controls. Proliferative responses were measured as 
counts per minute (cpm) after pulsing with tritiated 3[H] thy-
midine (1 µCi per well; MP Biomedicals, Santa Ana, Califor-
nia) for 16 h using a Wallac liquid scintillation counter (Per-
kin Elmer, Waltham, Massachusetts) [20,21]. Stimulation in-
dices were then derived by dividing the cpm values obtained 
in peptide-stimulated cultures by those of background val-
ues obtained in medium controls [19].
2.6. Determination of antigen specificity of Myhc-α-reactive 
T cells by IAk/dextramer staining
IAk dextramers for Myhc-α 334–352 and RNase 43–56 were 
derived as described previously [22]. Briefly, soluble IAk 
molecules containing the above peptide sequences were 
expressed in baculovirus and the proteins were biotinylat-
ed [23]. Multimerized dextramers were generated by mix-
ing biotinylated IAk proteins with phycoerythrin-conjugat-
ed dextran molecules at a 1:20 molar ratio [22].To determine 
the frequency of antigen-specific cells, lymphocytes derived 
from CVB3-infected mice were stimulated with Myhc-α 334–
352 (100 µg/ml) for 2 days and maintained in growth medi-
um containing IL-2 (eBioscience, San Diego, California; Ad-
vanced Biotechnologies, Columbia, Maryland). Viable lym-
phoblasts were harvested on day 5 by Ficoll-Hypaque den-
sity gradient centrifugation, and the cells were maintained 
in IL-2 medium. The staining was performed on day 9 using 
IAk/Myhc-α 334–352 or RNase 43–56 dextramers, anti-CD4 
(eBioscience), and 7-aminoactinomycin D (7-AAD; Invitro-
gen, Carlsbad, California) as previously described [22,23]. 
After acquiring the cells by flow cytometry (FC; FACSCali-
bur, BD Biosciences, San Diego, California), percentages of 
dextramer-positive (dext+) cells were determined in the live 
(7-AAD-) CD4+ subset using Flow Jo software (Tree Star, 
Ashland, Oregon).
For enumeration of Myhc-α-specific cells ex vivo,CD4 T 
cells were enriched by magnetic separation (IMag, BD Bio-
sciences, San Jose, California), and the cells were treated with 
neuraminidase (NASE; Type X from Clostridium perfringens, 
0.7 units/ml, Sigma-Aldrich, St. Louis, Missouri) in serum-
free 1 × DMEM medium prior to dextramer staining, as we 
have described previously [21,23]. After washing once with 
5 ml of 1 × PBS, cells were stained with IAk dextramers, an-
ti-CD4, and 7-AAD, and dext+ cells were analyzed in the live 
(7-AAD-) CD4 subset as above. To determine the frequen-
cies of Myhc-α-reactive cells in the hearts, after the animals 
were euthanized, hearts were perfused with an injection of 
10 ml of 1 × cold PBS into the left cardiac ventricles, then 
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changes. The dose of 50 TCID50/animal resulted in 20% mor-
tality of the infected animals, whereas doses ranging from 
1×103 to 1×105 TCID50 led to high mortalities (89% to 100%) 
as early as 5 to 14 days PI (Table 1). Regardless of mortalities, 
however, 50% of infected animals had myocardial necrosis, 
which occurred in association with pancreatitis, but the de-
gree of inflammatory changes varied. For example, high viral 
doses (1×103 to 1×105 TCID50) resulted in mild inflammatory 
heart lesions composed of fewer perivascular lymphocytes, 
but all animals had severe necrosis; on the other hand, at low 
doses the inflammatory foci were widespread (50 TCID50: 
11.90 ± 4.50; 100 TCID50: 14.30 ± 5.72), but necrosis was noted 
in only 34% of mice (Figure 1 and Table 1). Such an inverse 
relationship might be due to limited time available for im-
mune events to set in as a result of early mortalities. How-
ever, necrosis and atrophic changes were evident in the pan-
creases of all infected animals (Figure 1). These features were 
lacking in tissues harvested from the control group (data not 
shown). Based on our data, we chose a dose range of 50 to 
100 TCID50/animal for further experiments to investigate the 
induction of autoreactive T cells in infected mice.
3.2. A/J mice infected with CVB3 show generation of Myhc-
α-reactive cells in their periphery
To address the hypothesis that CVB3 infection induces gen-
eration of autoreactive cells, we used Myhc-α as a putative 
target cardiac antigen [31]. Two approaches were adopted 
to evaluate the generation of Myhc-α-reactive CD4 T cells: 1) 
proliferative response to Myhc-α 334–352 based on 3[H] thy-
midine incorporation assay, and 2) IAk/dextramer staining. 
Lymphocytes isolated from A/J mice infected with CVB3 
on day 21 PI were tested for responses to Myhc-α 334–352 
or RNase 43–56 (control). Figure 2A shows that the cells re-
sponded dose dependently to Myhc-α 334–352, and the re-
sponse was specific since the cells did not respond to the con-
trol peptide. Stimulation indices obtained for each peptide 
revealed 2.5-fold higher proliferative responses for Myhc-α 
334–352 than for RNase 43–56. We next tested antigen speci-
ficity of these cells using IAk/dextramers which permitted us 
to enumerate the frequencies of Myhc-α -specific CD4 T cells 
by FC [22]. CD4 T cells were enriched from infected mice by 
magnetic separation and treated with NASE prior to dex-
tramer staining [22]. NASE treatment is critical for ex vivo 
determination of antigen-specific cells since it facilitates ef-
ficient binding of class II tetramers or dextramers [23]. Un-
der these conditions, we estimated the frequencies of Myhc-
α-specific cells to be 0.1 ± 0.003%, whereas the staining inten-
sity obtained with RNase 43–56 dextramers was significantly 
low (p = 0.002; Figure 2B). We verified these results by stim-
ulating the lymphocytes harvested from CVB3-infected mice 
with Myhc-α 334–352, collecting lymphoblasts on day 9 post-
stimulation, and staining with dextramers. Myhc-α 334–352 
dextramers detected 3 times more CD4 cells than were de-
tected with RNase 43–56 dextramers (0.46 ± 0.08% vs. 0.14 
± 0.01%; p = 0.015; Figure 2C). Expectedly, the number of 
Myhc-α-reactive cells detected in Myhc-α 334–352-stimulat-
ed cultures increased by 5-fold over ex vivo analysis. The 
specificity of T cell responses to Myhc-α 334–352 was fur-
ther verified by stimulating the lymphocytes obtained from 
CVB3-infected mice with a non-myocarditogenic heart anti-
animals were euthanized on day 14 and the tissues were eval-
uated for histology. In addition, the animals that received sa-
line and Con-A-stimulated lymphocytes obtained from naïve 
mice were used as controls (0.5×107 cells/animal; n=3). To 
provide specificity for CVB3-mediated myocarditis, we used 
influenza virus strain, A/Puerto Rico 8/34 (PR8) grown in 
the allantoic cavity of embryonated hen’s eggs [29]. Groups 
of A/J mice (n = 5) were infected intranasally with 500 egg 
infectious units of virus in 30 µl of 1 × PBS under light isoflu-
rane anesthesia and after 10 days, animals were euthanized 
to obtain lymphocytes from LN and spleens. Cells were stim-
ulated with Con-A as above for 2 days and viable cells were 
transferred into naïve mice (0.3×107 cells/animal). Animals 
were euthanized on day 14 posttransfer and hearts and pan-
creases were harvested for histology. Likewise, to provide 
specificity for Myhc, adoptive transfer experi ments were 
performed using lymphocytes sensitized with IRBP 201–216 
as an irrelevant antigen. Briefly, A/J mice were immunized 
with IRBP 201–216, an IAk-binder [30] in complete Freund’s 
adjuvant (50 µg/mouse: n = 2) and 10 days later, the ani-
mals were euthanized to harvest lymphocytes from LN and 
spleens. Cells were stimulated with Con-A for 2 days and vi-
able cells were administered into naïve mice (0.75×107 cells/
animal), and on day 14, the animals were euthanized to col-
lect tissues for histology.
2.9. Detection of CVB3 RNA by RT-PCR
Total RNA was isolated from heart and pancreas homo-
genates, Con-A-stimulated lymphoblasts used for adoptive 
transfer experiments, Vero cells cultured with the cell medi-
um used for suspending the lymphoblasts or Vero cells infect-
ed with CVB3 using RLT buffer containing guanidium thio-
cyanate (RNeasy kit, Qiagen, Valencia, California), and the 
samples were treated with RNAse-free DNAse I according to 
the manufacturer’s recommendations (Qiagen). To make cer-
tain that the RNA samples were free of residual DNA, a sec-
ond round of DNAse digestion was performed using ampli-
fication grade DNAse I (Invitrogen), and cDNAs were syn-
thesized utilizing Superscript III reverse transcriptase kit as 
recommended (Invitrogen). CVB3 viral protein (VP)1 frag-
ment was then amplified by PCR using VP1-specific prim-
ers (forward, 5’TTGCATATGGCCCAGTGGAAG3’; reverse, 
5’TGTGGATCCTTATTGCCTAGTAGTGGTAACTC3’). The 
PCR products were stained with ethidium bromide and re-
solved in 1% agarose gel electrophoresis.
2.10. Statistics
Differences in the T cell proliferative responses, frequen-
cies of dext+ cells and cytokine secretion between treatment 
groups were analyzed by Student’s t. P ≤ 0.05 values were 
considered significant.
3. Results
3.1. Establishment of CVB3-induced myocarditis in A/J mice
We used myocarditis-susceptible A/J mice to induce the 
disease with CVB3. Determination of an autoimmune re-
sponse in this model required establishment of a disease 
course in which the virus does not induce significant mor-
talities. This was achieved using different amounts of virus 
inocula and assessing disease severity by evaluating hearts 
and pancreases for histological evidence of inflam matory 
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fected animals implies that autoreactive T cells appear sec-
ondary to virus infection, likely as the result of virus-in-
duced tissue damage.
3.5. Myhc-α-reactive CD4 T cells generated in response to CVB3 
infection contain a high frequency of IL-17-producing cells
To determine the pathogenic potential of Myhc-α-reactive 
cells generated in mice infected with CVB3, we determined 
their cytokine-producing abilities by intracellular staining. 
Frequencies of cytokine-producing cells were enumerated 
in naïve mice to determine background response of cytokine 
production prior to exposure to the virus. The naïve T cell 
repertoires contained predominantly IL-2-producing cells 
(data not shown), whereas cells capable of producing oth-
er cytokines except IFN-γ were lacking (1.25±0.03%; Figure 
5). Examination of cytokine-producing abilities of lympho-
cytes harvested from CVB3-infected mice ex vivo revealed 
elevated levels of all cytokines tested – Th1, Th2, and Th17 
– but among these, frequencies of cells secreting IL-22 (2.75± 
0.34%; p=0.002) and GM-CSF (0.36±0.03%; p=0.006) were 
significantly increased, followed by cells producing IFN-γ 
(2.69±0.66%), IL-17F (1.56±1.25%), IL-10 (0.89±0.29%), IL-17A 
(0.24±0.07%), and IL-4 (0.19±0.08%; Figure 5). Next, we eval-
uated the frequencies of cytokine-secreting autoreactive T 
cells by stimulating lymphocytes harvested from CVB3-in-
fected mice with Myhc-α 334–352, resulting in the expansion 
of IFN-γ-, IL-4-, IL-17A-, IL-17F-, and GM-CSF-producing 
cells, but the prominent cytokine was IL-17A (0.51±0.04%, 
p=0.033; Figure 5). The data suggest that Myhc-α-reactive 
cells generated in CVB3-infected mice possess the pathogen-
ic characteristics of autoreactive T cells as indicated by their 
preferential ability to produce IL-17.
3.6. T lymphocytes generated from CVB3-infected mice can 
induce myocarditis in naïve mice
To determine if the autoreactive cells generated in mice 
infected with CVB3 have an ability to induce myocarditis, 
we derived lymphoblasts from infected mice by stimulating 
lymphocytes with Con-A and injecting them into naïve ir-
radiated recipients as previously described [35,36]. One of 
the three recipients of cells derived from CVB3-infected mice 
showed epicarditis (Figure 6A: i), myocarditis (Figure 6A: 
ii) and myocardial fibrosis (Figure 6A: iii) and the pancre-
as was not affected and the infiltrates were predominantly 
composed of lymphocytes similar to EAM [19]. Likewise, the 
animals (2/2) that received Myhc-α 334–352-sensitized CD4 
T cells also showed cardiac damage as indicated by hemor-
rhagic necrosis (Figure 6B: i) and mineralization (Figure 6B: 
ii). On the contrary, none of the saline-receiving 
gen, TNI 157–171 [32]. Figure 2D shows that the lymphocytes 
obtained from CVB3-infected mice did not respond to TNI 
157–171 and the response was similar to control, RNase 43–
56. Finally, we asked whether Myhc-α-reactive T cells can 
be generated in myocarditis-resistant mice. To address this 
question, we used B10.A mice bearing H-2a haplotype sim-
ilar to A/J mice which are resistant to the development of 
myocarditis induced with CVB3 [33,34]. In a T cell prolifera-
tion assay, we noted that lymphocytes obtained from infect-
ed B10.A mice did not respond to Myhc-α 334–352 (Figure 
2E). Overall, the data obtained with dextramer stainings and 
proliferative responses corroborate each other and provide 
evidence for the generation of Myhc-α-reactive cells in mice 
susceptible to CVB3 infection.
3.3. Myhc-α-specific cells infiltrate into the hearts of CVB3-
infected mice
We sought to verify whether Myhc-α-specific cells infiltrate 
the hearts. MNC were harvested from hearts of CVB3-infect-
ed mice and stained with Myhc-α 334–352 or RNase 43–56 
dextramers, and frequencies of Myhc-α-dext+ cells were de-
termined by FC. We prepared pools of MNC from at least 
seven hearts for each experiment because the yield of cells 
per heart was low (6×104/heart). The majority of infiltrates 
were non-T cells, and staining for different immune cell 
markers revealed the presence of B220+ (8.5%), GR1+ (6.5%), 
CD11b+ (2.8%), and CD11c+ cells (1.4%). In contrast, CD3+ T 
cells formed a minor component consisting of CD4+ (8%) and 
CD8+ (4%) T cells (Figure 3A). Dextramer analysis of CD4 T 
cells revealed autoreactive cells as evidenced by the presence 
of an estimated 2.2±0.16% of Myhc-α 334–352 dext+ cells, as 
opposed to 0.6±0.07% of RNase 43–56 cells, an four-fold 
difference (p=0.011, Figure 3B). The data provide evidence 
that Myhc-α 334–352-reactive CD4 T cells infiltrate the hearts 
during the course of CVB3 infection in A/J mice.
3.4. Naïve A/J mice do not carry Myhc-α-reactive CD4 T 
cells in their peripheral repertoires
One critical question we needed to address was whether 
Myhc-α-reactive cells generated in CVB3-infected mice arise 
from expansion of a preexisting repertoire of autoreactive 
cells or appear as a new population of cells after viral infec-
tion. We obtained lymphocytes from naïve (uninfected) A/J 
mice and evaluated their reactivity to Myhc-α 334–352 by T 
cell proliferation assay and dextramer staining. Using RNase 
43–56 as control, we noted that T cells did not respond to 
Myhc-α 334–352 (Figure 4A) nor was there any staining with 
Myhc-α dextramers (Figure 4B). Absence of Myhc-α-reactive 
cells in the naïve repertoires but their presence in CVB3-in-
Table 1 CVB3-induced myocarditis in A/J mice.
Does (TCID50/animal   Incidence n (%)   Mortality n (%)   Severity of lesions     Inflammatory foci (mean±SEM)
              Mild  Moderate  Severe
2.5×101         1/3 (33.33)       1/3 (33.33)    0   1    0    66.66±6.66
5.0×101      12/55 (21.81)    11/55 (20)    3   3    6    11.90±4.49
1.0×102      13/33 (39.39)    22/35 (62.85)    6   2    5    14.30±5.72
1.0×103         5/9 (55.55)       9/9 (100)    3   2    0    2.55±1.36
1.0×104         4/9 (44.44)       8/9 (88.88)    4   0    0    1.13±0.52
1.0×105         5/8 (62.5)       8/8 (100)    4   1    0    2.00±0.93
Inflammation scoring scale: mild multifocal: 1-5 foci; moderate multifocal to coalescing: 6-25 foci; and severe: 26 foci and above.
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Figure 1 Histological evaluation of hearts and pancreases from mice infected with CVB3. Groups of 6- to 8-week old A/J mice were infected with 
CVB3 (1×102 TCID50/animal) i.p., and animals were killed on day 21 PI. Hearts (A to D) and pancreases (E and F) were collected for histological 
evaluation of inflammatory changes by H and E staining. (A) Mild lesion with a few perivascular lymphocytes (arrow) and dark pink fibers in-
dicative of necrosis (circle). (B) Moderate lesions with more foci and necrosis (arrows). (C) Severe inflammatory lesion with widespread areas of 
mineralization (arrows). (D) Necrosis, mineralization, or lymphocytic and histiocytic infiltrates (arrows). (E) Pancreatic ducts (arrow) and small 
acinii composed of atrophic acinar cells and (F) widespread acinar cell necrosis with nuclear pyknosis (arrows) and loss of cytoplasmic details.
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Figure 2 A/J mice infected with CVB3 show the generation of Myhc-a 334–352 reactive cells. (A) Proliferative response. A/J mice were infected 
with CVB3 (5×101 to 1×102 TCID50/animal); after 21 days, animals were sacrificed and spleens and LN were harvested to prepare lymphocytes. 
Cells were stimulated with Myhc-α 334–352 for 2 days, then pulsed with 3[H] thymidine for 16 h, and proliferative responses were measured 
as cpm. (B) Dextramer staining ex vivo. CD4 T cells isolated from CVB3-infected mice were treated with NASE prior to staining with IAk/dex-
tramers, anti-CD4, and 7-AAD. After acquiring the cells by FC, dext+ cells were analyzed in the live (7-AAD-), CD4 subset. Control, RNase 43–
56. (C) Dextramer staining of Myhc-α 334–352-stimulated cells. Lymphocytes were obtained from CVB3-infected mice as above; cells were stim-
ulated with Myhc-a 334–352 for 2 days and cultures were maintained in IL-2 medium. Viable lymphoblasts were harvested on day 9 poststim-
ulation and stained with IAk/dextramers, anti-CD4 and 7-AAD. After acquiring the cells by FC, dext+ cells were analyzed in the live (7-AAD-), 
CD4 subset. Control, RNase 43–56. (D) Proliferative response to TNI 157–171. Lymphocytes harvested from CVB3-infected A/J mice were stim-
ulated with TNI 157–171 and RNase 43–56 for 2 days and the proliferative responses were measured as cpm after pulsing with 3[H] thymidine 
for 16 h. (E) Proliferative response to Myhc-α 334–352 in B10.A mice. B10.A mice were infected with CVB3 (1×102 TCID50/mouse) and after 21 
days, the animals were euthanized to prepare single cell suspensions from LN and spleens. After stimulating the cells with Myhc-α 334–352 and 
RNase 43–56 for 2 days, and pulsing with 3[H] thymidine, proliferative responses were measured as above.
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that received saline (lanes, 1–6) or cells (lanes, 7–12; Figure 
7). The data suggest that CVB3 infection can lead to the gen-
eration of Myhc-α-reactive cells and they can contribute to 
the development of myocarditis in infected animals.
4. Discussion
In this report, we show that the T cell repertoire generated 
in response to CVB3 infection contains a population of Myhc-
α-reactive cells. We provide four lines of evidence for a pro-
posal that the autoreactive cells are generated secondary to 
CVB3 infection and play a role in the mediation of viral myo-
carditis: a) the peripheral repertoire of infected but not naïve 
mice contains a population of Myhc-α 334–352 dext+ cells; 
b) the inflammatory infiltrates of hearts from CVB3-infected 
mice reveal the presence of Myhc-α-reactive cells; c) lympho-
cytes stimulated with Myhc-α 334–352 contain high frequen-
cies of IL-17-producing cells, a cytokine generally implicat-
ed in various organ-specific diseases including autoimmune 
and CVB3 myocarditis or DCM [37–39]; and d) T cells gen-
erated from CVB3-infected mice can induce disease in na-
ïve mice reminiscent of autoimmune myocarditis induced 
with Myhc-α 334–352 [16,19]. All these studies employed 
A/J mice, which are highly susceptible to both human-iso-
late CVB3 (Nancy strain) infection, and Myhc-α 334–352-in-
duced EAM, whose disease pathologies resemble each oth-
animals (Figure 6C), or those that received Con-A-stimulat-
ed naïve lymphocytes (Figure 6D), influenza virus-sensitized 
lymphocytes (Figure 6E) and IRBP 201–216-reactive lympho-
cytes (Figure 6F) showed any evidence of inflammation in 
the hearts or in the pancreases. To verify whether myocardi-
tis occurring in the recipient mice was caused by residual vi-
rus present in the infused cells, we tested the lymphocyte 
cultures used for infusions for the presence of virus by CPE, 
and for the presence of viral nucleic acids by RT-PCR. Vero 
cells infected with CVB3 as a positive control showed cytol-
ysis, but such a phenomenon was absent when the culture 
medium was passed thrice blindly, including the viral nucle-
ic acids as verified for CVB3 VP1 (819 bp) by RT-PCR (lane, 
14; Figure 7). Likewise, the presence of CVB3 RNA was not 
revealed in the evaluation of hearts and pancreases of mice 
Figure 3 Myhc-α-specific CD4 T cells infiltrate into the hearts of 
CVB3-infected mice. (A) Subsets of heart infiltrates. Groups of mice 
infected with CVB3 (5×101 TCID50/animal) were sacrificed on day 21 
PI, and hearts were collected to isolate MNC. Cells were stained with 
the indicated markers and percentages of each were determined by 
FC. The data represent an experiment involving 13 mice. (B) IAk/
dextramer staining. Heart MNC isolated from CVB3-infected mice 
were stained with Myhc-α 334–352 or RNase 43–56 (control) dex-
tramers and anti-CD4 and 7-AAD. Cells were acquired by FC, and 
percentages of dext+ cells were enumerated in the live CD4 subset. 
Representative data from two individual experiments, each involv-
ing 7 to 8 mice, are shown.
Figure 4 Naïve mice do not carry Myhc-α 334–352-reactive T cells 
in their periphery. (A) Proliferative response. Lymphocytes were 
isolated from spleens and LN harvested from naïve mice, and cells 
were stimulated with Myhc-α 334–352 or RNase 43–56 for 2 days; 
after pulsing with 3[H] thymidine for 16 h, proliferative responses 
were measured as cpm. (B) Dextramer staining ex vivo. CD4 T cells 
isolated from naïve mice were treated with NASE prior to staining 
with IAk/dextramers followed by anti-CD4 and 7-AAD. After ac-
quiring the cells by FC, dext+ cells were analyzed in the live (7-AAD-
), CD4 subset. Control, RNase 43–56. FC plots representing three in-
dividual experiments each involving three mice are shown.
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cells, the role of IL-4- and IL-10-producing Th2 cells is more 
complex. Mice infected with CVB3 produce IL-4, which can 
dampen the disease-protective Th1 response. IL-4 also can 
suppress the production of innate inflammatory mediators, 
such as metalloproteinases, and favors recovery from viral 
myocarditis [45]. On the contrary, macrophages or human fi-
broblasts exposed to CVB3 produce both anti-inflammatory 
(IL-10) and inflammatory [IL-1β, IL-6 and tumor necrosis fac-
tor (TNF)-α] cytokines, and induction of IL-10 is thought to 
favor development of the chronic disease course by inhibit-
ing the disease-protective IFN-γ secretion [46,47]. Recently, 
it was shown that IL-17 promotes viral myocarditis by en-
hancing viral replication and that neutralization of IL-17 us-
ing cytokine-specific antibody treatment suppresses the se-
verity of disease induced with CVB3 [39]. We observed that 
lymphocytes derived from CVB3-infected mice contain a 
significant proportion of IL-22 (2.75 ± 0.34%) and GM-CSF 
(0.36 ±0.03%). Similar profiles have been earlier reported 
[48]. However, after stimulation with Myhc-α 334–352, fre-
quencies of IL-17-producing cells were increased suggesting 
a selective expansion of Th17 cytokine-secreting cells by an 
autoantigen. We and others have previously demonstrated 
that the lymphocytes generated from Myhc-α 334–352-im-
munized mice contain predominantly IL-17-producing cells 
[4,19,37]. Thus our data support the contention that IL-17 is 
a myocarditogenic cytokine [49], and IL-17-producing au-
toreactive T cells could be generated as a secondary event 
in infectious myocarditis and contribute to cardiac damage.
CVB3 is a cytolytic cardiotropic virus that causes extensive 
damage in the target organ, the heart. The dosages used in 
this study were low compared to other models of CVB3-in-
duced myocarditis due to the high rate of mortality in the 
A/J mice with this viral strain [14,50]. At dosages of 103 to 
105 infectious units, mortality was greater than 80%, whereas 
low doses (up to 1×102) induced myocarditis with low mor-
talities. Cardiovirulent CVB3 causes extensive pancreatic ne-
crosis, which may account for the early mortalities in these 
mice [51]. We attempted to determine whether myocardi-
tis that occurred in CVB3-infected mice might be due to the 
generation of autoreactive CD4 cells, and our data support 
this possibility. We noted that Myhc-α-reactive cells are gen-
erated in CVB3-infected but not naïve A/J mice (0.1%, Fig-
ure 2B vs 0.04%, Figure 4B) and antigen-specific T cells infil-
trate into the hearts of infected animals. The absence of such 
a repertoire in naïve mice suggests their appearance second-
ary to virus infection. Whether naïve A/J mice carry T cell 
repertoires for other epitopes of Myhc-α remains to be test-
ed. This possibility seems less likely because Myhc-α 334–
352 was identified as the only immunodominant and patho-
genic epitope in this mouse strain [16]. These observations, 
however, do not rule out the possibility that virus-specific 
cells are not involved. The question is: how do they mediate 
cardiac damage in the absence of replicating viral particles? 
This can be explained by two scenarios: 1) Virus-specific cy-
totoxic lymphocytes may expand from a pool of memory T 
cell population during subsequent exposures to CVB3, and 
the effector cells thus derived can kill virus-infected cardio-
myocytes through MHC class I-dependent pathways. Like-
wise, Th cells capable of secreting inflammatory cytokines 
also can potentially expand and contribute to tissue injury or 
can do so through the production of autoantibodies. In sup-
er [11]. Therefore, the CVB3-induced myocarditis model pro-
vides a useful framework to extrapolate the observations 
made in mice to humans.
Autoimmune theory has been proposed in the pathogenesis 
of CVB3 infection, particularly in the heart, because the dis-
ease assumes a biphasic pattern: acute or viremic and chron-
ic or non-viremic phases, although in the latter phase, the vi-
rus can persist but in a defective form [8,9]. Generally, auto-
immunity becomes a prime suspect in chronic diseases when 
inflammation persists in the absence of detectable infectious 
particles. The challenge, then, is to provide support for the 
concept that autoimmunity is a component of the disease 
process to establish a cause-and-effect relationship.
Extensive investigation of the role of cell-mediated immune 
response in CVB3 infection has shown that it requires partic-
ipation of both CD4 and CD8 T cells. Mice deficient in CD4 
become resistant to CVB3-induced myocarditis, whereas 
CD8-deficient mice develop more or less severe myocarditis 
[40,41]. Conversely, mice deficient in both CD4 and CD8 are 
better protected from the disease [40]. In addition, γδ T cells 
promote susceptibility to CVB3-induced myocarditis by po-
tentiating the expansion of Th1 cells [15]. These observations 
indicate that multiple immune cells are involved in the me-
diation of viral myocarditis. Generally, T cell-mediated or-
gan-specific autoimmune diseases such as experimental au-
toimmune encephalomyelitis/multiple sclerosis are primari-
ly driven by Th1 and Th17 cells [42]. An exception to this par-
adigm was earlier proposed to be myocarditis, in that Th1 
cells offer disease protection. For example, IFN-γ knockout 
mice become susceptible to CVB3-myocarditis, and treat-
ment with IFN-γ ameliorates the disease [43]. Likewise, tis-
sue-specific ectopic expression of IFN-. within the pancre-
atic beta cells prevents the disease [44]. In contrast to Th1 
Figure 5 Myhc-α 334–352-sensitized CD4 T cells from CVB3- infect-
ed mice contain a high proportion of IL-17-producing cells. Lym-
phocytes harvested from naïve mice or from CVB3-infected mice on 
day 21 PI were stimulated with PMA and ionomycin in the presence 
of monensin for 5 h. After staining with anti-CD4 and 7-AAD, cells 
were fixed and permeabilized followed by incubation with a panel 
of Th1, Th2 and Th17 cytokine antibodies. Cells were acquired by FC 
and frequencies of cytokine-producing cells were determined in the 
live (7-AAD-), CD4 subset. To determine the frequencies of cytokine-
producing autoreactive T cells, lymphocytes obtained from CVB3-
infected mice were stimulated with Myhc-a 334–352 for 2 days; cul-
tures were maintained in IL-2 medium. Viable lymphoblasts har-
vested on day 5 were stimulated with PMA/ionomycin and percent-
ages of cytokine-producing cells were determined as above.
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trate into the hearts of infected animals. Because the naïve 
mice lack Myhc-α-reactive cells in their periphery, we pro-
pose that generation of autoreactive T cells occurs as a sec-
ondary event to cardiac damage. This means previously in-
visible self-proteins, as in the case of Myhc-α, become targets 
for immune attack after viral damage. While our data pro-
vide a proof-of-concept for this theory, we cannot rule out 
the contribution of autoreactive T cells for other self-antigens 
that might be released during the course of CVB3 infection 
as a result of epitope spreading [54]. To investigate this pos-
port of this theory, mice infected with repeated bouts of vi-
rus developed dilated hearts in association with increased 
TNF-α secretion and CVB3-reactive antibodies, but with 
minimal inflammatory cell infiltrations [52]. 2) Virus-specific 
cells may contain repertoires of cells specific to cardiac pro-
teins other than Myhc, and existence of such cross-reactive T 
cell repertoires, if any, can induce cardiac injury through an-
tigenic mimicry [53].
In summary, we provide evidence that CVB3-infected mice 
show the generation of Myhc-α-reactive cells and they infil-
Figure 6 T cells generated from CVB3-infected mice can induce myocarditis in naïve mice. Groups of A/J mice (n=20) were infected with CVB3 
and after 21 days, lymphocytes were stimulated with Con-A for 2 days, viable lymphoblasts were administered i.p., into the naïve irradiated 
mice (n=3), and each mouse also received PT i.p. The animals were euthanized on day 21 posttransfer, and hearts and pancreases were collect-
ed for histological evaluation of inflammatory changes by H and E staining. Panels (A: i), (A: ii), and (A: iii) represent heart sections from mice 
that received the cells, respectively denoting epicarditis, myocarditis, myocardial fibrosis accompanied with inflammatory infiltrates (arrows), 
and normal pancreas. Likewise, Myhc-α 334–352-sensitized CD4 T cells were also generated from CVB3-infected mice as described in the Mate-
rials and methods and transferred into naïve mice. Panels (B: i) and (B: ii) respectively represent hemorrhagic necrosis and mineralization in the 
hearts (arrows) but with normal pancreas. Panels (C), (D), (E) and (F) represent histological evaluation of hearts and pancreases obtained from 
animals that received saline, Con-A-stimulated naïve lymphocytes, influenza virus-sensitized lymphocytes and IRBP 201–216-reactive cells gen-
erated from A/J mice. Bar=20 µm for all except for heart in saline group (C): 50 µm.
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sibility, we are generating class II dextramers for other car-
diac antigens such as BCKD, ANT, and TNI, which will per-
mit us to enumerate the precursor frequencies of their T cell 
repertoires in CVB3-infected mice. These observations pro-
vide new insights into the immunopathogenesis of CVB3 in-
fection, including therapeutic modalities.
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